Table 1.
Clinical and demographic characteristics in patients with upper GI cancer and age matched healthy controls.
Table 2.
Baseline assessment of neuropathy in patients with upper GI cancer and age matched healthy controls.
Table 3.
Demographic characteristics and clinical findings of the patients with upper GI cancer before and after chemotherapy.
Fig 1.
CCM image of healthy control (A) and a patient with gastric cancer before (B) and after (C) chemotherapy (Red arrows: main nerve, yellow arrows: branches). (D) Line chart showing consistently reduced CNFL in 13 patients with upper GI cancer at baseline and after the third cycle of chemotherapy (each line represents data from an individual patient).